Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · IEX Real-Time Price · USD
46.84
-1.65 (-3.40%)
At close: Jul 17, 2024, 4:00 PM
46.70
-0.14 (-0.30%)
After-hours: Jul 17, 2024, 4:28 PM EDT

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $79.41M in the twelve months ending March 31, 2024, with 70.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.29M with 8.67% year-over-year growth. In the year 2023, Kymera Therapeutics had annual revenue of $78.59M with 67.84% growth.

Revenue (ttm)
$79.41M
Revenue Growth
+70.16%
P/S Ratio
36.19
Revenue / Employee
$424,668
Employees
187
Market Cap
2.87B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202378.59M31.77M67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M114.00%
Dec 31, 202034.03M31.10M1,059.99%
Dec 31, 20192.93M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition